(Q34722540)

4 August 2017

title

Flunarizine enhancement of melphalan activity against drug-sensitive/resistant rhabdomyosarcoma (English)

1 reference

4 August 2017

1 reference

2

H S Friedman

1 reference

4 August 2017

7

D D Bigner

1 reference

4 August 2017

S M Castellino

1

1 reference

4 August 2017

G B Elion

3

1 reference

4 August 2017

E T Ong

4

1 reference

4 August 2017

S L Marcelli

5

1 reference

4 August 2017

R Page

6

1 reference

4 August 2017

M W Dewhirst

8

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 June 1995

1 reference

British Journal of Cancer

4 August 2017

published in

1 reference

4 August 2017

volume

71

1 reference

4 August 2017

issue

6

1 reference

4 August 2017

page(s)

1181-1187

1 reference

The effect of flunarizine on erythrocyte suspension viscosity under conditions of extreme hypoxia, low pH, and lactate treatment

4 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033851

Blood flow to primary tumors and lymph node metastases in SMT-2A tumor-bearing rats following intravenous flunarizine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033851

Mechanism of melphalan resistance developed in vitro in human melanoma cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033851

Effects of verapamil and alcohol on blood flow, melphalan uptake and cytotoxicity, in murine fibrosarcomas and human melanoma xenografts

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033851

Altered pharmacokinetics in the mechanism of chemosensitization: effects of nitroimidazoles and other chemical modifiers on the pharmacokinetics, antitumour activity and acute toxicity of selected nitrogen mustards

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033851

Establishment of a cisplatin-resistant human ovarian cancer cell line.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033851

Melphalan transport, glutathione levels, and glutathione-S-transferase activity in human medulloblastoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033851

Glutathione and glutathione S-transferases in a human plasma cell line resistant to melphalan.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033851

Phase II treatment of medulloblastoma and pineoblastoma with melphalan: clinical therapy based on experimental models of human medulloblastoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033851

Non-chemotherapeutic agents that potentiate chemotherapy efficacy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033851

Characterization of the human cell line TE671.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033851

Establishment of a melphalan-resistant rhabdomyosarcoma xenograft with cross-resistance to vincristine and enhanced sensitivity following buthionine sulfoximine-mediated glutathione depletion.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033851

Calcium antagonism and calcium entry blockade

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033851

Increased lethality of calmodulin antagonists and bleomycin to human bone marrow and bleomycin-resistant malignant cells.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033851

Chemotherapy of subcutaneous and intracranial human medulloblastoma xenografts in athymic nude mice

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033851

Blood perfusion measurements in human tumours: evaluation of laser Doppler methods

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033851

Therapeutic analysis of melphalan-resistant human rhabdomyosarcoma xenograft TE-671 MR

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033851

Perivascular oxygen tensions in a transplantable mammary tumor growing in a dorsal flap window chamber

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033851

Modulation of melphalan uptake in murine L5178Y lymphoblasts in vitro by changes in ionic environment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033851

Establishment of a human medulloblastoma cell line

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033851

Growth and chemotherapeutic response in athymic mice of tumors arising from human glioma-derived cell lines.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033851

Reduction in cellular glutathione by buthionine sulfoximine and sensitization of murine tumor cells resistant to L-phenylalanine mustard.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033851

Transport of melphalan by sensitive and resistant L1210 cells

26 October 2018

1 reference

12 December 2020

Inhibition of Cultured Human Tumor Cell Oxygen Utilization by Chlorpromazine

1 reference

12 December 2020

Bepridil and flunarizine as calmodulin inhibitors

1 reference

12 December 2020

Potentiation of Bleomycin Lethality by Anticalmodulin Drugs: A Role for Calmodulin in DNA Repair

1 reference

12 December 2020

Effects of a calcium-antagonist (flunarizine) on the in vitro growth of B16 mouse melanoma cells

1 reference

12 December 2020

Phase II testing of melphalan in children with newly diagnosed rhabdomyosarcoma: a model for anticancer drug development

1 reference

12 December 2020

Phase I trial of combined therapy with bleomycin and the calmodulin antagonist, trifluoperazine

1 reference

12 December 2020

Enhancement of the anti-tumor effect of melphalan in experimental mice by some vaso-active agents

1 reference

12 December 2020

Calcium antagonists as radiation modifiers: site specificity in relation to tumor response

1 reference

12 December 2020

Effect of flunarizine on micro-regional distributions of intravascular HbO2 saturations in RIF-1 and KHT sarcomas

1 reference

12 December 2020

Effects of the calcium channel blocker flunarizine on the hemodynamics and oxygenation of tumor microvasculature

1 reference

12 December 2020

Therapeutic potentiation of nitrosoureas using chlorpromazine and caffeine in the treatment of murine tumors

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1995.230

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference

4 August 2017

1 reference